-
Crimean-Congo haemorrhagic fever (CCHF) virus-specific antibody detection in blood donors, Castile-León, Spain, summer 2017 and 2018
- Lía Monsalve Arteaga1 , Juan Luis Muñoz Bellido2,3,4 , María Carmen Vieira Lista1 , María Belén Vicente Santiago1 , Pedro Fernández Soto1 , Isabel Bas5 , Nuria Leralta5 , Fernando de Ory Manchón6 , Ana Isabel Negredo5 , María Paz Sánchez Seco5 , Montserrat Alonso Sardón1 , Sonia Pérez González7 , Ana Jiménez del Bianco7 , Lydia Blanco Peris7 , Rufino Alamo-Sanz8 , Roger Hewson9 , Moncef Belhassen-García1 , Antonio Muro1
-
View Affiliations Hide AffiliationsAffiliations: 1 Infectious and Tropical Diseases Group (e-INTRO). IBSAL-CIETUS (Biomedical Research Institute of Salamanca-Research Center for Tropical Diseases at the University of Salamanca), Faculty of Pharmacy, University of Salamanca, Salamanca, Spain 2 Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, CSIC, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain 3 Servicio de Microbiología y Parasitología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain 4 Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, Salamanca, Spain 5 Arbovirus and Imported Viral Diseases Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Red de Investigación Colaborativa en Enfermedades Tropicales, Madrid, Spain 6 Centro Nacional de Microbiología, Ciber en Salud Pública (CIBERESP), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain 7 Center for Hemodonation and Hemotherapy of Castilla y León (CHEMCYL), Valladolid, Spain 8 Consejería de Sanidad Junta Castilla y León, Valladolid, Spain 9 Public Health England, Porton Down, Wiltshire, Salisbury, United KingdomMoncef Belhassen-Garcíabelhassen usal.es
-
View Citation Hide Citation
Citation style for this article: Monsalve Arteaga Lía, Muñoz Bellido Juan Luis, Vieira Lista María Carmen, Vicente Santiago María Belén , Fernández Soto Pedro, Bas Isabel, Leralta Nuria, de Ory Manchón Fernando, Negredo Ana Isabel, Sánchez Seco María Paz, Alonso Sardón Montserrat, Pérez González Sonia, Jiménez del Bianco Ana, Blanco Peris Lydia, Alamo-Sanz Rufino, Hewson Roger, Belhassen-García Moncef, Muro Antonio. Crimean-Congo haemorrhagic fever (CCHF) virus-specific antibody detection in blood donors, Castile-León, Spain, summer 2017 and 2018. Euro Surveill. 2020;25(10):pii=1900507. https://doi.org/10.2807/1560-7917.ES.2020.25.10.1900507 Received: 05 Aug 2019; Accepted: 07 Dec 2019
Abstract
Crimean-Congo haemorrhagic fever virus (CCHFV) is considered an emerging or even a probable re-emerging pathogen in southern Europe. Presence of this virus had been reported previously in Spain in 2010.
We aimed to evaluate the potential circulation of CCHFV in western Spain with a serosurvey in asymptomatic adults (blood donors).
During 2017 and 2018, we conducted a CCHFV serosurvey in randomly selected asymptomatic blood donors from western Spain. Three assays using specific IgG antibodies against CCHFV were performed: the VectoCrimea ELISA test, an in-house ELISA and indirect immunofluorescence (EuroImmun) test with glycoprotein and nucleoprotein.
A total of 516 blood donors participated in this cross-sectional study. The majority of the study participants were male (68.4%), and the mean age was 46.3 years. Most of the participants came from rural areas (86.8%) and 68.6% had contact with animals and 20.9% had animal husbandry practices. One in five participants (109/516, 21.1%) were engaged in at-risk professional activities such as agriculture and shepherding, slaughtering, hunting, veterinary and healthcare work (mainly nursing staff and laboratory technicians). A total of 15.3% of the participants were bitten by ticks in the days or months before the date of sampling. We detected anti-CCHFV IgG antibodies with two diagnostic assays in three of the 516 individuals and with one diagnostic assay in six of the 516 individuals.
Seroprevalence of CCHFV was between 0.58% and 1.16% in Castile-León, Spain. This is the first study in western Spain that showed circulation of CCHFV in healthy people.
Article metrics loading...
Full text loading...
References
-
Ballinger MJ, Medeiros AS, Qin J, Taylor DJ. Unexpected differences in the population genetics of phasmavirids (Bunyavirales) from subarctic ponds. Virus Evol. 2017;3(1):vex015. https://doi.org/10.1093/ve/vex015 PMID: 28744370
-
Leblebicioglu H, Eroglu C, Erciyas-Yavuz K, Hokelek M, Acici M, Yilmaz H. Role of migratory birds in spreading Crimean-Congo hemorrhagic fever, Turkey. Emerg Infect Dis. 2014;20(8):1331-4. https://doi.org/10.3201/eid2008.131547 PMID: 25062428
-
Spengler JR, Bente DA. Crimean-Congo hemorrhagic fever in Spain - New arrival or silent resident? N Engl J Med. 2017;377(2):106-8. https://doi.org/10.1056/NEJMp1707436 PMID: 28700846
-
Estrada-Peña A, de la Fuente J. The ecology of ticks and epidemiology of tick-borne viral diseases. Antiviral Res. 2014;108:104-28. https://doi.org/10.1016/j.antiviral.2014.05.016 PMID: 24925264
-
Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 2013;100(1):159-89. https://doi.org/10.1016/j.antiviral.2013.07.006 PMID: 23906741
-
Aslam S, Latif MS, Daud M, Rahman ZU, Tabassum B, Riaz MS, et al. Crimean-Congo hemorrhagic fever: Risk factors and control measures for the infection abatement. Biomed Rep. 2016;4(1):15-20. https://doi.org/10.3892/br.2015.545 PMID: 26870327
-
Kasi KK, Sas MA, Sauter-Louis C, Gethmann JM, Groschup MH, Conraths FJ. Risk factors for Crimean-Congo hemorrhagic fever virus infection in Livestock in Pakistan. Int J Infect Dis. 2019;79:137. https://doi.org/10.1016/j.ijid.2018.11.335
-
Sidira P, Maltezou HCC, Haidich A-BA-B, Papa A. Seroepidemiological study of Crimean-Congo haemorrhagic fever in Greece, 2009-2010. Clin Microbiol Infect. 2012;18(2):E16-9. https://doi.org/10.1111/j.1469-0691.2011.03718.x PMID: 22192082
-
World Health Organization (WHO). 2017 Annual review of diseases prioritized under the Research and Development Blueprint. Meeting report. Geneva, Switzerland: Informal consultation 24-25 Jan 2017. Available from: https://www.who.int/blueprint/what/research-development/2017-Prioritization-Long-Report.pdf?ua=1
-
World Health Organization (WHO). An R&D Blueprint for Action to Prevent Epidemics: Plan of Action. Geneva: WHO; 2016. Available from: https://www.who.int/blueprint/about/r_d_blueprint_plan_of_action.pdf
-
World Health Organization (WHO). Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens. Funding & coordination models for preparedness and response. Geneva: WHO; 2016. Available from: https://www.who.int/blueprint/what/improving-coordination/workstream_5_document_on_financing.pdf
-
Gunes T, Engin A, Poyraz O, Elaldi N, Kaya S, Dokmetas I, et al. Crimean-Congo hemorrhagic fever virus in high-risk population, Turkey. Emerg Infect Dis. 2009;15(3):461-4. https://doi.org/10.3201/eid1503.080687 PMID: 19239765
-
Midilli K, Gargili A, Ergonul O, Sengöz G, Ozturk R, Bakar M, et al. Imported Crimean-Congo hemorrhagic fever cases in Istanbul. BMC Infect Dis. 2007;7(1):54. https://doi.org/10.1186/1471-2334-7-54 PMID: 17553137
-
Eurosurveillance editorial team. Increase in cases of Crimean-Congo haemorrhagic fever, Turkey, 2006. Euro Surveill. 2006;11(7):E060720.2. PMID: 16966763
-
Papa A, Maltezou HC, Tsiodras S, Dalla VG, Papadimitriou T, Pierroutsakos I, et al. A case of Crimean-Congo haemorrhagic fever in Greece, June 2008. Euro Surveill. 2008;13(33):18952. https://doi.org/10.2807/ese.13.33.18952-en PMID: 18761893
-
Christova I, Younan R, Taseva E, Gladnishka T, Trifonova I, Ivanova V, et al. Hemorrhagic fever with renal syndrome and Crimean-Congo hemorrhagic fever as causes of acute undifferentiated febrile illness in Bulgaria. Vector Borne Zoonotic Dis. 2013;13(3):188-92. https://doi.org/10.1089/vbz.2011.0938 PMID: 23421884
-
Roth C. Outbreak of Crimean-Congo haemorrhagic fever in Kosovo – update. Euro Surveill. 2001;5(25):1731. https://doi.org/10.2807/esw.05.25.01731-en
-
Papa A, Bino S, Llagami A, Brahimaj B, Papadimitriou E, Pavlidou V, et al. Crimean-Congo hemorrhagic fever in Albania, 2001. Eur J Clin Microbiol Infect Dis. 2002;21(8):603-6. https://doi.org/10.1007/s10096-002-0770-9 PMID: 12226691
-
Dreshaj S, Ahmeti S, Ramadani N, Dreshaj G, Humolli I, Dedushaj I. Current situation of Crimean-Congo hemorrhagic fever in Southeastern Europe and neighboring countries: a public health risk for the European Union? Travel Med Infect Dis. 2016;14(2):81-91. https://doi.org/10.1016/j.tmaid.2016.03.012 PMID: 27044611
-
Tall A, Sall AA, Faye O, Diatta B, Sylla R, Faye J, et al. [Two cases of Crimean-Congo haemorrhagic fever (CCHF) in two tourists in Senegal in 2004]. Bull Soc Pathol Exot. 2009;102(3):159-61. PMID: 19739410
-
Jauréguiberry S, Tattevin P, Tarantola A, Legay F, Tall A, Nabeth P, et al. Imported Crimean-Congo hemorrhagic fever. J Clin Microbiol. 2005;43(9):4905-7. https://doi.org/10.1128/JCM.43.9.4905-4907.2005 PMID: 16145173
-
Barr DA, Aitken C, Bell DJ, Brown CS, Cropley I, Dawood N, et al. First confirmed case of Crimean-Congo haemorrhagic fever in the UK. Lancet. 2013;382(9902):1458. https://doi.org/10.1016/S0140-6736(13)61718-3 PMID: 24243135
-
Filipe AR, Calisher CH, Lazuick J. Antibodies to Congo-Crimean haemorrhagic fever, Dhori, Thogoto and Bhanja viruses in southern Portugal. Acta Virol. 1985;29(4):324-8. PMID: 2864836
-
Estrada-Peña A, Palomar AM, Santibáñez P, Sánchez N, Habela MA, Portillo A, et al. Crimean-Congo hemorrhagic fever virus in ticks, Southwestern Europe, 2010. Emerg Infect Dis. 2012;18(1):179-80. https://doi.org/10.3201/eid1801.111040 PMID: 22261502
-
Negredo A, de la Calle-Prieto F, Palencia-Herrejón E, Mora-Rillo M, Astray-Mochales J, Sánchez-Seco MP, et al. Autochthonous Crimean-Congo hemorrhagic fever in Spain. N Engl J Med. 2017;377(2):154-61. https://doi.org/10.1056/NEJMoa1615162 PMID: 28700843
-
Cajimat MNB, Rodriguez SE, Schuster IUE, Swetnam DM, Ksiazek TG, Habela MA, et al. Genomic characterization of Crimean-Congo hemorrhagic fever virus in hyalomma tick from Spain, 2014. Vector Borne Zoonotic Dis. 2017;17(10):714-9. https://doi.org/10.1089/vbz.2017.2190 PMID: 28836897
-
Sierra MJ, García San Miguel L, García M, Vila B, Suárez B, Monge S, et al. Informe de situación y evaluación del riesgo de transmisión de Fiebre Hemorrágica de Crimea-Congo (FHCC) en España. [Status report and risk assessment of transmission of Crimean-Congo haemorrhagic fever (CCHF) in Spain]. Madrid: Centro de Coordinación de Alertas y Emergencias Sanitarias, Ministerio de Sanidad, Consumo y Bienestar Social; 2019. Spanish. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/analisisituacion/doc/ER_FHCC.pdf
-
Negredo A, Habela MÁ, Ramírez de Arellano E, Diez F, Lasala F, López P, et al. Survey of Crimean-Congo hemorrhagic fever enzootic focus, Spain, 2011-2015. Emerg Infect Dis. 2019;25(6):1177-84. https://doi.org/10.3201/eid2506.180877 PMID: 31107219
-
Spengler JR, Estrada-Peña A. Host preferences support the prominent role of Hyalomma ticks in the ecology of Crimean-Congo hemorrhagic fever. PLoS Negl Trop Dis. 2018;12(2):e0006248. https://doi.org/10.1371/journal.pntd.0006248 PMID: 29420542
-
Palomar AM, Portillo A, Santibáñez S, García-Álvarez L, Muñoz-Sanz A, Márquez FJ, et al. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015. Enferm Infecc Microbiol Clin. 2017;35(6):344-7. https://doi.org/10.1016/j.eimc.2017.01.009 PMID: 28291670
-
National Statistics Institute (INE). España en cifras 2019. Población. [Spain in numbers. Population]. Madrid: INE; 2019. Spanish. Available from: https://www.ine.es/prodyser/espa_cifras/2019/10/#zoom=z
-
Dowall SD, Richards KS, Graham VA, Chamberlain J, Hewson R. Development of an indirect ELISA method for the parallel measurement of IgG and IgM antibodies against Crimean-Congo haemorrhagic fever (CCHF) virus using recombinant nucleoprotein as antigen. J Virol Methods. 2012;179(2):335-41. https://doi.org/10.1016/j.jviromet.2011.11.020 PMID: 22155577
-
Tezer H, Polat M. Diagnosis of Crimean-Congo hemorrhagic fever. Expert Rev Anti Infect Ther. 2015;13(5):555-66. https://doi.org/10.1586/14787210.2015.1021782 PMID: 25746112
-
Burt FJ. Laboratory diagnosis of Crimean-Congo hemorrhagic fever virus infections. Future Virol. 2011;6(7):831-41. https://doi.org/10.2217/fvl.11.47
-
Németh V, Oldal M, Egyed L, Gyuranecz M, Erdélyi K, Kvell K, et al. Serologic evidence of Crimean-Congo hemorrhagic fever virus infection in Hungary. Vector Borne Zoonotic Dis. 2013;13(4):270-2. https://doi.org/10.1089/vbz.2012.1011 PMID: 23421895
-
Papa A, Dalla V, Papadimitriou E, Kartalis GNN, Antoniadis A. Emergence of Crimean-Congo haemorrhagic fever in Greece. Clin Microbiol Infect. 2010;16(7):843-7. https://doi.org/10.1111/j.1469-0691.2009.02996.x PMID: 19845692
-
Vanhomwegen J, Alves MJ, Zupanc TA, Bino S, Chinikar S, Karlberg H, et al. Diagnostic assays for Crimean-Congo hemorrhagic fever. Emerg Infect Dis. 2012;18(12):1958-65. https://doi.org/10.3201/eid1812.120710 PMID: 23171700
-
de Ory F, Guisasola M-E, Balfagón P, Sanz JC. Comparison of commercial methods of immunoblot, ELISA, and chemiluminescent immunoassay for detecting type-specific herpes simplex viruses-1 and -2 IgG. J Clin Lab Anal. 2018;32(1):e22203. https://doi.org/10.1002/jcla.22203 PMID: 28332725
-
Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009;49(Suppl 2):1S-29S. https://doi.org/10.1111/j.1537-2995.2009.02279.x PMID: 19686562
-
European Centre for Disease Control and Prevention ECDC). Rapid risk assessment: Crimean–Congo haemorrhagic fever in Spain. Stockholm: ECDC; 2016. Available from: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-crimean-congo-haemorrhagic-fever-spain-9-september-2016
-
Mertens M, Schmidt K, Ozkul A, Groschup MH. The impact of Crimean-Congo hemorrhagic fever virus on public health. Antiviral Res. 2013;98(2):248-60. https://doi.org/10.1016/j.antiviral.2013.02.007 PMID: 23458713
-
López-Vélez R, Molina Moreno R. [Climate change in spain and risk of infectious and parasitic diseases transmitted by arthropods and rodents]. Rev Esp Salud Publica. 2005;79(2):177-90. PMID: 15913053
-
Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760. https://doi.org/10.1371/journal.pntd.0001760 PMID: 22880140
-
Yactayo S, Staples JE, Millot V, Cibrelus L, Ramon-Pardo P. Epidemiology of chikungunya in the Americas. J Infect Dis. 2016;214(suppl 5):S441-5. https://doi.org/10.1093/infdis/jiw390 PMID: 27920170
-
de La Rocque S, Balenghien T, Halos L, Dietze K, Claes F, Ferrari G, et al. A review of trends in the distribution of vector-borne diseases: is international trade contributing to their spread? Rev Sci Tech. 2011;30(1):119-30. https://doi.org/10.20506/rst.30.1.2018 PMID: 21809758
-
Kilpatrick AM, Randolph SE. Drivers, dynamics, and control of emerging vector-borne zoonotic diseases. Lancet. 2012;380(9857):1946-55. https://doi.org/10.1016/S0140-6736(12)61151-9 PMID: 23200503
Data & Media loading...